This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Discover the importance of using asset allocation to balance risk and return. This strategy can enhance your investment performance.
28,655 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Micron stock is gaining today as analysts turn more constructive and data-center demand shows resilience. This articl...
The SEC has published a five-year plan prioritizing digital assets and blockchain, signaling a shift toward a formal ...
As AI data centers surge, the race for reliable, green energy accelerates. This analysis explains how Oklo could beco...
Hewlett Packard Enterprise shares have climbed as demand for AI infrastructure accelerates. This article breaks down ...
As the three-year mark of the Ripple-SEC ruling arrives, XRP has moved from regulator target to institutional asset, ...
When a major fund buys more while a stock falls, it sets up a compelling investing puzzle. This piece explains what t...
Copart stock dropped today after the latest earnings report, shaking up portfolios that rely on salvage auctions and ...
Investors are keen on Ingevity (NGVT) 2026 earnings as the company reports Q1 results. This article breaks down the n...
Marvell Technology surprised the market with a stronger revenue outlook. This in-depth guide examines what that means...
A practical, investor-friendly look at Gambling.com Group's Q1 2026 earnings. This deep dive breaks down revenue driv...
SpaceX is trading far above its IPO price. This article explains what that gain means for early investors, what could...